Sarepta Therapeutics Announces Preliminary Financial Results for the Third Quarter Ended September 30, 2023
CAMBRIDGE, Mass., Oct. 12, 2023 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced preliminary financial results for its third quarter ended September 30, 2023. Sarepta expects its net product revenues…